How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Culture Devices Market
- By Product Type: Automated Blood Culture Systems, Manual Blood Culture Systems, Blood Culture Bottles, Blood Culture Media, Blood Culture Accessories
- By Microorganism Detection Technology: Colorimetric Detection, Fluorescence Detection, Pressure Sensor Detection, CO2 Sensor Detection, Turbidity Detection
- By End User: Hospitals, Diagnostic Laboratories, Ambulatory Care Centers, Research Institutes, Blood Banks
- By Application: Bacteremia Detection, Fungemia Detection, Sepsis Diagnosis, Antimicrobial Susceptibility Testing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Automated Blood Culture Systems leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Blood Culture Devices Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Microorganism Detection Technology 5
End User 5
Application 4
Companies profiled
bioMérieux
Becton Dickinson and Company (BD)
Thermo Fisher Scientific
Siemens Healthineers
Sysmex Corporation
Beckman Coulter (Danaher Corporation)
bio-Rad Laboratories
Abbott Laboratories
Luminex Corporation
Hologic Inc.
Cepheid (Danaher Corporation)
Quidel Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →bioMérieux
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sysmex Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Beckman Coulter (Danaher Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →bio-Rad Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Abbott Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Luminex Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hologic Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cepheid (Danaher Corporation)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Quidel Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Ortho Clinical Diagnostics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →F. Hoffmann-La Roche AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Molecular Devices
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$4,892M by 2033 · 6.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Automated Blood Culture Systems48.9
- Manual Blood Culture Systems21.6
- Blood Culture Bottles12.0
- Blood Culture Media9.0
- Blood Culture Accessories8.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$946.4M → $1,644M · 7.2%
Europe$659.6M → $1,045M · 5.9%
Asia Pacific$602.2M → $945.3M · 5.8%
Latin America$372.8M → $602.3M · 6.2%
Middle East and Africa$286.8M → $502.8M · 7.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.852026
6.862027
6.882028
6.892029
6.912030
6.922031
6.922032
6.952033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- bioMérieux27.5
- Becton Dickinson and Company (BD)10.1
- Thermo Fisher Scientific9.8
- Siemens Healthineers9.4
- Sysmex Corporation5.5
- Beckman Coulter (Danaher Corporation)9.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type24.7%
Microorganism Detection Technology23.7%
End User18.7%
Application32.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.7
- Europe22.1
- Asia Pacific19.9
- Latin America12.7
- Middle East and Africa10.6
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| bioMérieux | 92 | 98 | 83 | 87 | 91 | 92 | 91 |
| Becton Dickinson and Company (BD) | 76 | 81 | 77 | 68 | 73 | 71 | 74 |
| Thermo Fisher Scientific | 74 | 73 | 78 | 68 | 64 | 70 | 71 |
| Siemens Healthineers | 79 | 72 | 70 | 79 | 64 | 70 | 72 |
| Sysmex Corporation | 71 | 76 | 56 | 56 | 59 | 70 | 65 |
| Beckman Coulter (Danaher Corporation) | 62 | 46 | 58 | 57 | 57 | 62 | 57 |
| bio-Rad Laboratories | 40 | 46 | 61 | 53 | 60 | 54 | 52 |
| Abbott Laboratories | 39 | 39 | 47 | 58 | 37 | 59 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- bioMérieux
- Becton Dickinson and Company (BD)
- Thermo Fisher Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| bioMérieux | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Becton Dickinson and Company (BD) | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Thermo Fisher Scientific | ◐ | − | ◐ | − | − | ◐ |
| Siemens Healthineers | ◐ | ◐ | ✓ | ✓ | − | ◐ |
| Sysmex Corporation | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Beckman Coulter (Danaher Corporation) | ◐ | − | − | − | ◐ | − |
| bio-Rad Laboratories | − | ◐ | − | − | ◐ | − |
| Abbott Laboratories | ◐ | ◐ | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1bioMérieux91
2Becton Dickinson and Company (BD)74
3Siemens Healthineers72
4Thermo Fisher Scientific71
5Sysmex Corporation65
6Beckman Coulter (Danaher Corporation)57
7bio-Rad Laboratories52
8Abbott Laboratories47
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
bioMérieux
Challenger3
Strong scale, closing on the leaders.
Becton Dickinson and Company (BD)Thermo Fisher ScientificSiemens Healthineers
Contender2
Focused players with pockets of strength.
Sysmex CorporationBeckman Coulter (Danaher Corporation)
Niche2
Specialists in a single segment or region.
bio-Rad LaboratoriesAbbott Laboratories
Go-to-market strategy
Land Product Type in North America, then scale across Blood Culture Devices Market — a $355M beachhead inside a $4.72B market.
Beachhead (SOM)$355Mobtainable near-term
Serviceable (SAM)$1.87Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Automated Blood Culture Systems
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Manual Blood Culture Systems
Strong fit — clear ROI and a fast path to value.
End user68 fit
Blood Culture Bottles
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Microorganism Detection Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel30%
Digital / self-serve17%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Culture Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified22%
Evaluation14%
Closed-won7%
$16.5KCAC
$66KLTV
4.0:1LTV : CAC
< 3 moCAC payback
Investment thesis
Blood Culture Devices Market is a resilient opportunity — $7.30B by 2033, compounding at 3.9%.
TAM · 2025$5.37Btoday
TAM · 2033$7.30Bforecast
CAGR3.9%2027–2033
Cumulative$56.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.30BTotal addressable market
SAM$2.60BServiceable available market
SOM$562MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.30BLarge & growingTAM by 2033 at 3.9% CAGR
$2.60BServiceable nowreachable with today’s model
$562MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.69BBear2.5% CAGR
$7.30BBase3.9% CAGR
$9.35BBull5.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Microorganism Detection Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Culture Devices Market — a $8.60B market by 2033. Plan: grow share from 11.7% to 18.9%.
Market size · 2033$8.60Btotal addressable
Market CAGR9.0%2027–2033
Target share18.9%from 11.7% today
Revenue ambition$1.63Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.7% | 18.9% | Ahead |
| Revenue | $1.01B | $1.63B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 34.9% | 41.2% | On track |
| Customer retention | 91.9% | 96.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Microorganism Detection Technology capability
A defensible second engine — invest in Microorganism Detection Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Microorganism Detection Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $231M capacity & capability investment
- Greenlight bolt-on M&A in Microorganism Detection Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentBehind
Sales deck · value proposition
Win the Blood Culture Devices Market conversation — a $7.19B market you can size, segment and defend in minutes.
Market size · 2033$7.19Btotal opportunity
Growth8.8%CAGR to 2033
Addressable buyers969+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 4 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
bioMérieuxBecton Dickinson and Company (BD)Thermo Fisher ScientificSiemens HealthineersSysmex CorporationBeckman Coulter (Danaher Corporation)bio-Rad LaboratoriesAbbott Laboratories+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Culture Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Culture Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Culture Test Device Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBlood Dialysis Water Treatment Equipment Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportBlood Disease Drugs Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportBlood Donation Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBlood Donor Armchairs Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportBlood Electric Chair Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlood Factors Market
Market size, share, segmentation and regional forecast.
$416M market · 2025 base year
View reportBlood Flow Measurement Devices (Ultrasonic Doppler, Laser Doppler and Electromagnetic Blood Flowmeters) Market
Market size, share, segmentation and regional forecast.
$814M market · 2025 base year
View reportBlood Flow Restriction Bands Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlood Gas Analyzer with Touchscreen Market
Market size, share, segmentation and regional forecast.
$698M market · 2025 base year
View reportBlood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBlood Gas Electrolyte Analyzer Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.